BioXcel Therapeutics, Inc. (BTAI) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 33.91M | 44.69M | 44.4M | 25.24M | 37.78M | 37.39M | 47.79M | 64.18M | 80.92M | 72.14M | 98.74M | 138.24M |
| Cash & Short-Term Investments | 17.18M | 28.41M | 37.32M | 17.43M | 31.01M | 29.85M | 40.39M | 56.27M | 74.14M | 65.22M | 89.96M | 127.55M |
| Cash Only | 17.18M | 28.41M | 37.32M | 17.43M | 31.01M | 29.85M | 40.39M | 56.27M | 74.14M | 65.22M | 89.96M | 127.55M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 216K | 233K | 0 | 17K | 0 | 131K | 3K | 812K | 378K | 71K | 735K | 431K |
| Days Sales Outstanding | 98.08 | 83.73 | - | 12.89 | - | 16.84 | 175.19 | 49.04 | 35.1 | 98.61 | 157.29 | 71.09 |
| Inventory | 500K | 722K | 459K | 506K | 642K | 679K | 1.52M | 2.68M | 2.44M | 1.99M | 2.02M | 1.93M |
| Days Inventory Outstanding | 161.26 | 1.7K | 4.04K | 488.17 | 4.25K | 121.86 | 165.32 | 3.76K | 1.28K | 258.28 | 354.25 | 6.78K |
| Other Current Assets | 16.01M | 15.31M | 934K | 2.13M | 1.39M | 1.44M | 1.4M | 1.64M | 1.86M | 2.08M | 2.17M | 4.64M |
| Total Non-Current Assets | 117K | 231K | 389K | 546K | 789K | 944K | 1.1M | 1.25M | 1.41M | 1.56M | 1.71M | 1.86M |
| Property, Plant & Equipment | 117K | 231K | 389K | 546K | 702K | 857K | 1.01M | 1.17M | 1.32M | 1.47M | 1.62M | 1.77M |
| Fixed Asset Turnover | 1.18x | 0.83x | 0.21x | 0.19x | 0.22x | 0.39x | 0.20x | 0.89x | 0.42x | 0.24x | 0.20x | 0.25x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 87K | 87K | 87K | 87K | 87K | 87K | 87K | 87K |
| Total Assets | 34.02M | 44.92M | 44.79M | 25.79M | 38.57M | 38.34M | 48.89M | 65.44M | 82.32M | 73.7M | 100.45M | 140.1M |
| Asset Turnover | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x |
| Asset Growth % | -11.77% | 17.16% | -8.39% | -60.59% | -53.15% | -47.98% | -51.33% | -53.29% | -54.29% | -64.2% | -58.97% | -43.56% |
| Total Current Liabilities | 54.99M | 53.93M | 37.8M | 33.38M | 25.55M | 22.23M | 25.56M | 27.29M | 31.48M | 27.27M | 39.41M | 34.74M |
| Accounts Payable | 16.25M | 14.7M | 16.28M | 16.69M | 15.45M | 15.99M | 14.89M | 13.26M | 17.22M | 13.65M | 10.67M | 11.2M |
| Days Payables Outstanding | 4.08K | 44.53K | 137.87K | 13.67K | 101.06K | 1.71K | 1.11K | 22.37K | 8.89K | 1.57K | 1.97K | 33.15K |
| Short-Term Debt | 22.43M | 24.93M | 16.98M | 11.22M | 5.61M | 0 | 0 | 0 | 353K | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 85K | 0 | 0 | 0 |
| Other Current Liabilities | 16.32M | 14.26M | 4.41M | 41K | 54K | 142K | 10.19M | 2.44M | 12.48M | 163K | 735K | 4.16M |
| Current Ratio | 0.62x | 0.83x | 1.17x | 0.76x | 1.48x | 1.68x | 1.87x | 2.35x | 2.57x | 2.65x | 2.51x | 3.98x |
| Quick Ratio | 0.61x | 0.82x | 1.16x | 0.74x | 1.45x | 1.65x | 1.81x | 2.25x | 2.49x | 2.57x | 2.45x | 3.92x |
| Cash Conversion Cycle | -3.82K | -42.75K | - | -13.17K | - | -1.57K | -766.04 | -18.56K | -7.58K | -1.21K | -1.45K | -26.3K |
| Total Non-Current Liabilities | 84.57M | 86.45M | 95.91M | 100.08M | 103.19M | 109.21M | 108.97M | 112.45M | 123.2M | 102.94M | 101.65M | 99.49M |
| Long-Term Debt | 77.86M | 84.66M | 92.3M | 97.47M | 99.92M | 102.51M | 104.44M | 103.01M | 101.63M | 100.6M | 99.09M | 96.85M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 65K | 161K | 256K | 350K | 440K | 529K | 617K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 6.72M | 1.79M | 3.6M | 2.61M | 3.27M | 6.63M | 4.37M | 9.19M | 21.22M | 1.91M | 2.03M | 2.03M |
| Total Liabilities | 139.57M | 140.38M | 133.71M | 133.46M | 128.74M | 131.44M | 134.53M | 139.74M | 154.69M | 130.21M | 141.06M | 134.23M |
| Total Debt | 100.29M | 109.59M | 109.29M | 108.94M | 105.88M | 102.95M | 104.97M | 103.26M | 102.34M | 101.38M | 99.96M | 97.8M |
| Net Debt | 83.11M | 81.18M | 71.97M | 91.51M | 74.86M | 73.09M | 64.58M | 46.99M | 28.2M | 36.16M | 10M | -29.75M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | 16.68x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -2.41x | -1.85x | -6.07x | -3.54x | - | -1.69x | -2.60x | -1.24x | -6.43x | -5.48x | -14.52x | -15.42x |
| Total Equity | -105.54M | -95.46M | -88.92M | -107.67M | -90.17M | -93.1M | -85.63M | -74.3M | -72.36M | -56.51M | -40.61M | 5.86M |
| Equity Growth % | -17.05% | -2.54% | -3.84% | -44.91% | -24.61% | -64.76% | -110.88% | -1367.07% | -236.52% | -173.6% | -131.98% | -96.43% |
| Book Value per Share | -8.65 | -7.82 | -6.26 | -13.73 | -18.65 | -30.64 | -32.32 | -29.53 | -37.51 | -30.70 | -22.20 | 3.21 |
| Total Shareholders' Equity | -105.54M | -95.46M | -88.92M | -107.67M | -90.17M | -93.1M | -85.63M | -74.3M | -72.36M | -56.51M | -40.61M | 5.86M |
| Common Stock | 27K | 76K | 73K | 60K | 59K | 49K | 42K | 40K | 34K | 30K | 29K | 29K |
| Retained Earnings | -732.78M | -720.09M | -707.55M | -676.64M | -657.45M | -650.2M | -639.34M | -625.69M | -617.39M | -590.6M | -568.34M | -517.86M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |